Atlas Trials

A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide

Clinical trial NCT05414123 · TERMINATED

Trial details

NCT number
NCT05414123
Sponsor
Biocept, Inc.
Status
TERMINATED
Study type
OBSERVATIONAL
Leptomeningeal MetastasisLeptomeningeal DiseaseLeptomeningeal NeoplasmsBreast CancerNon-Small Cell Lung Cancer
Start date
2022-09-07
Primary completion
2023-10-13
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.